Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Alternative Therapies in Health and Medicine|March 18, 2006
Effectiveness of acupuncture in the treatment of fibromyalgiaBetsy B Singh, Wen-Shuo Wu, San Hong Hwang, et al.Lancet (London, England)|June 8, 2026
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trialMichelle Welch, Thomas Forst, Weiping Jia, et al.Asia-Pacific Journal of Clinical Oncology|August 24, 2016
Brain metastasis features and association with tumor epidermal growth factor receptor mutation in patients with adenocarcinoma of the lungYung-Hung Luo, Chieh-Hung Wu, Chu-Yun Huang, et al.Plos One|April 7, 2018
Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD)Qiang Shi, Ko-Jen Li, Tamas Treuer, et al.American Journal of Clinical Dermatology|March 1, 2023
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)Ohsang Kwon, Maryanne M Senna, Rodney Sinclair, et al.The British Journal of Dermatology|March 31, 2023
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)Antonio Torrelo, Barbara Rewerska, Maria Galimberti, et al.International Journal of Rheumatic Diseases|November 16, 2019
Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trialsYing-Chou Chen, Dae Hyun Yoo, Chang Keun Lee, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Association between tumor epidermal growth factor receptor mutation and pulmonary tuberculosis in patients with adenocarcinoma of the lungsYung-Hung Luo, Chieh-Hung Wu, Wen-Shuo Wu, et al.The New England Journal of Medicine|June 22, 2025
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 DiabetesJulio Rosenstock, Stanley Hsia, Luis Nevarez Ruiz, et al.The British Journal of Dermatology|September 14, 2023
When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trialsBrett King, Jerry Shapiro, Manabu Ohyama, et al.Pageof 3